Computational and experimental advances in drug repositioning for accelerated therapeutic stratification

Khader Shameer, Benjamin Readhead, Joel T. Dudley

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Drug repositioning is an important component of therapeutic stratification in the precision medicine paradigm. Molecular profiling and more sophisticated analysis of longitudinal clinical data are refining definitions of human diseases, creating needs and opportunities to re-target or reposition approved drugs for alternative indications. Drug repositioning studies have demonstrated success in complex diseases requiring improved therapeutic interventions as well as orphan diseases without any known treatments. An increasing collection of available computational and experimental methods that leverage molecular and clinical data enable diverse drug repositioning strategies. Integration of translational bioinformatics resources, statistical methods, chemoinformatics tools and experimental techniques (including medicinal chemistry techniques) can enable the rapid application of drug repositioning on an increasingly broad scale. Efficient tools are now available for systematic drug-repositioning methods using large repositories of compounds with biological activities. Medicinal chemists along with other translational researchers can play a key role in various aspects of drug repositioning. In this review article, we briefly summarize the history of drug repositioning, explain concepts behind drug repositioning methods, discuss recent computational and experimental advances and highlight available open access resources for effective drug repositioning investigations. We also discuss recent approaches in utilizing electronic health record for outcome assessment of drug repositioning and future avenues of drug repositioning in the light of targeting disease comorbidities, underserved patient communities, individualized medicine and socioeconomic impact.

Original languageEnglish (US)
Pages (from-to)5-20
Number of pages16
JournalCurrent Topics in Medicinal Chemistry
Volume15
Issue number1
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Drug Repositioning
Therapeutics
Precision Medicine
Community Medicine
Pharmaceutical Chemistry
Electronic Health Records
Vulnerable Populations
Rare Diseases
Computational Biology
Comorbidity

Keywords

  • Biomedical data mining
  • Disease comorbidity
  • Drug repositioning
  • Individualized medicine
  • Network analysis
  • Orphan disease
  • Translational bioinformatics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Computational and experimental advances in drug repositioning for accelerated therapeutic stratification. / Shameer, Khader; Readhead, Benjamin; Dudley, Joel T.

In: Current Topics in Medicinal Chemistry, Vol. 15, No. 1, 01.01.2015, p. 5-20.

Research output: Contribution to journalArticle

@article{caa6e7aa2dd34e85a34464b3e70ae518,
title = "Computational and experimental advances in drug repositioning for accelerated therapeutic stratification",
abstract = "Drug repositioning is an important component of therapeutic stratification in the precision medicine paradigm. Molecular profiling and more sophisticated analysis of longitudinal clinical data are refining definitions of human diseases, creating needs and opportunities to re-target or reposition approved drugs for alternative indications. Drug repositioning studies have demonstrated success in complex diseases requiring improved therapeutic interventions as well as orphan diseases without any known treatments. An increasing collection of available computational and experimental methods that leverage molecular and clinical data enable diverse drug repositioning strategies. Integration of translational bioinformatics resources, statistical methods, chemoinformatics tools and experimental techniques (including medicinal chemistry techniques) can enable the rapid application of drug repositioning on an increasingly broad scale. Efficient tools are now available for systematic drug-repositioning methods using large repositories of compounds with biological activities. Medicinal chemists along with other translational researchers can play a key role in various aspects of drug repositioning. In this review article, we briefly summarize the history of drug repositioning, explain concepts behind drug repositioning methods, discuss recent computational and experimental advances and highlight available open access resources for effective drug repositioning investigations. We also discuss recent approaches in utilizing electronic health record for outcome assessment of drug repositioning and future avenues of drug repositioning in the light of targeting disease comorbidities, underserved patient communities, individualized medicine and socioeconomic impact.",
keywords = "Biomedical data mining, Disease comorbidity, Drug repositioning, Individualized medicine, Network analysis, Orphan disease, Translational bioinformatics",
author = "Khader Shameer and Benjamin Readhead and Dudley, {Joel T.}",
year = "2015",
month = "1",
day = "1",
doi = "10.2174/1568026615666150112103510",
language = "English (US)",
volume = "15",
pages = "5--20",
journal = "Current Topics in Medicinal Chemistry",
issn = "1568-0266",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - Computational and experimental advances in drug repositioning for accelerated therapeutic stratification

AU - Shameer, Khader

AU - Readhead, Benjamin

AU - Dudley, Joel T.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Drug repositioning is an important component of therapeutic stratification in the precision medicine paradigm. Molecular profiling and more sophisticated analysis of longitudinal clinical data are refining definitions of human diseases, creating needs and opportunities to re-target or reposition approved drugs for alternative indications. Drug repositioning studies have demonstrated success in complex diseases requiring improved therapeutic interventions as well as orphan diseases without any known treatments. An increasing collection of available computational and experimental methods that leverage molecular and clinical data enable diverse drug repositioning strategies. Integration of translational bioinformatics resources, statistical methods, chemoinformatics tools and experimental techniques (including medicinal chemistry techniques) can enable the rapid application of drug repositioning on an increasingly broad scale. Efficient tools are now available for systematic drug-repositioning methods using large repositories of compounds with biological activities. Medicinal chemists along with other translational researchers can play a key role in various aspects of drug repositioning. In this review article, we briefly summarize the history of drug repositioning, explain concepts behind drug repositioning methods, discuss recent computational and experimental advances and highlight available open access resources for effective drug repositioning investigations. We also discuss recent approaches in utilizing electronic health record for outcome assessment of drug repositioning and future avenues of drug repositioning in the light of targeting disease comorbidities, underserved patient communities, individualized medicine and socioeconomic impact.

AB - Drug repositioning is an important component of therapeutic stratification in the precision medicine paradigm. Molecular profiling and more sophisticated analysis of longitudinal clinical data are refining definitions of human diseases, creating needs and opportunities to re-target or reposition approved drugs for alternative indications. Drug repositioning studies have demonstrated success in complex diseases requiring improved therapeutic interventions as well as orphan diseases without any known treatments. An increasing collection of available computational and experimental methods that leverage molecular and clinical data enable diverse drug repositioning strategies. Integration of translational bioinformatics resources, statistical methods, chemoinformatics tools and experimental techniques (including medicinal chemistry techniques) can enable the rapid application of drug repositioning on an increasingly broad scale. Efficient tools are now available for systematic drug-repositioning methods using large repositories of compounds with biological activities. Medicinal chemists along with other translational researchers can play a key role in various aspects of drug repositioning. In this review article, we briefly summarize the history of drug repositioning, explain concepts behind drug repositioning methods, discuss recent computational and experimental advances and highlight available open access resources for effective drug repositioning investigations. We also discuss recent approaches in utilizing electronic health record for outcome assessment of drug repositioning and future avenues of drug repositioning in the light of targeting disease comorbidities, underserved patient communities, individualized medicine and socioeconomic impact.

KW - Biomedical data mining

KW - Disease comorbidity

KW - Drug repositioning

KW - Individualized medicine

KW - Network analysis

KW - Orphan disease

KW - Translational bioinformatics

UR - http://www.scopus.com/inward/record.url?scp=84922285922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922285922&partnerID=8YFLogxK

U2 - 10.2174/1568026615666150112103510

DO - 10.2174/1568026615666150112103510

M3 - Article

C2 - 25579574

AN - SCOPUS:84922285922

VL - 15

SP - 5

EP - 20

JO - Current Topics in Medicinal Chemistry

JF - Current Topics in Medicinal Chemistry

SN - 1568-0266

IS - 1

ER -